Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vaccinex Inc (NQ: VCNX ) 6.740 -0.160 (-2.32%) Streaming Delayed Price Updated: 3:48 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 60,230 Open 7.050 Bid (Size) 6.660 (1) Ask (Size) 6.840 (2) Prev. Close 6.900 Today's Range 6.630 - 7.100 52wk Range 4.432 - 64.89 Shares Outstanding 65,941,086 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease at the Alzheimer’s Association International Conference, Philadelphia, July 31, 2024 July 17, 2024 Pepinemab is believed to block astrocyte reactivity, a key pathology driving Alzheimer’s progression From Vaccinex, Inc. Via GlobeNewswire Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease June 06, 2024 From Vaccinex, Inc. Via GlobeNewswire Performance YTD -36.13% -36.13% 1 Month +16.41% +16.41% 3 Month +13.64% +13.64% 6 Month -18.43% -18.43% 1 Year -88.74% -88.74% More News Read More 12 Health Care Stocks Moving In Friday's Intraday Session May 31, 2024 Via Benzinga VCNX Stock Earnings: Vaccinex Reported Results for Q1 2024 May 16, 2024 Via InvestorPlace VCNX Stock Earnings: Vaccinex Reported Results for Q4 2023 April 02, 2024 Via InvestorPlace Why Vaccinex (VCNX) Stock Is Trading Lower February 15, 2024 Via Benzinga Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 31, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session May 27, 2024 Via Benzinga Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update May 15, 2024 From Vaccinex, Inc. Via GlobeNewswire Why Vaccinex (VCNX) Stock Is Popping Off February 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session May 10, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session May 09, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session April 25, 2024 Via Benzinga Vaccinex Reports 2023 Financial Results and Provides Corporate Update April 02, 2024 From Vaccinex, Inc. Via GlobeNewswire Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules March 27, 2024 From Vaccinex, Inc. Via GlobeNewswire Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology February 21, 2024 From Vaccinex, Inc. Via GlobeNewswire Vaccinex, Inc. Announces Reverse Stock Split February 15, 2024 From Vaccinex, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's After-Market Session February 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session February 09, 2024 Via Benzinga Vaccinex Announces Pricing of $3.7 Million PIPE Financing February 07, 2024 From Vaccinex, Inc. Via GlobeNewswire Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule December 04, 2023 From Vaccinex, Inc. Via GlobeNewswire Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update November 13, 2023 From Vaccinex, Inc. Via GlobeNewswire Vaccinex Reports Positive Effect of Pepinemab Treatment on New Biomarker of Brain Inflammation in Neurodegenerative Diseases October 26, 2023 From Vaccinex, Inc. Via GlobeNewswire Vaccinex Reports Clinical Benefit in Interim Analyses from two Phase 2 Studies of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting October 31, 2023 From Vaccinex, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
